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Summary  Stress  exposure  activates  the  HPA-axis  and  results  in  the  release  of  corticosteroids
which bind  to  two  receptor  types  in  the  brain:  the  mineralocorticoid  receptor  (MR)  and  the
glucocorticoid  receptor  (GR).  While  the  role  of  the  GR  in  stress  reactivity  has  been  extensively
studied, the  MR  has  received  less  attention.  Nevertheless,  pioneering  in-depth  studies  over
the past  two  decades  have  shown  the  importance  of  the  brain  MR  in  the  processing  of  stress-
ful information.  Moreover,  a  membrane-bound  MR  mediating  the  rapid  effects  of  cortisol  was
recently discovered.  This  review  summarizes  how  the  MR  may  play  a  role  in  stress  resilience.
Both preclinical  and  clinical  studies  suggest  that  the  MR  is  an  important  stress  modulator  and
inﬂuences basal  as  well  as  stress-induced  HPA-axis  activity,  stress  appraisal,  and  fear-related
memories.  These  MR  effects  are  mediated  by  both  genomic  and  non-genomic  MRs  and  appear
to be  at  least  partially  sex-dependent.  Moreover,  the  majority  of  studies  indicate  that  high
MR functionality  or  expression  may  confer  resilience  to  traumatic  stress.  This  has  direct  clin-
ical implications.  First,  increasing  activity  or  expression  of  brain  MRs  may  prevent  or  reverse
symptoms  of  stress-related  depression.  Second,  individuals  with  a  relatively  low  MR  function-
ality may  possess  an  increased  stress  susceptibility  for  depression.  Nevertheless,  the  number
of clinical  MR  studies  is  currently  limited.  In  conclusion,  the  recent  emergence  of  the  MR  as  a
putative stress  resilience  factor  is  important  and  may  open  up  new  avenues  for  the  prevention
and treatment  of  psychiatric  disorders.
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1. Introduction
Exposure  to  stress  results  in  the  release  of  (nor)adrenaline
via  the  sympatho-adrenomedullary  system  and  the  release
of  corticosteroids  via  the  hypothalamic-pituitary-adrenal
(HPA)-axis.  Both  systems  act  in  concert  to  enable  an  indi-
vidual  to  successfully  adapt  to  a  changing  environment  (de
Kloet  et  al.,  2005).  Corticosteroid  hormones  (cortisol  in
humans  and  corticosterone  in  rodents)  ensure  that  sufﬁ-
cient  energy  is  available  and  dampen  the  immune  function.
At  the  same  time,  cortisol  exerts  negative  feedback  on  the
HPA-axis  and  prevents  a  damaging  overshoot.  An  efﬁcient
and  adaptive  stress  response  requires  a  rapid  activation  of
the  HPA-axis  after  stress  exposure  but  also  an  effective  ter-
mination  once  the  stressor  has  subsided  (McEwen,  2004).
Prolonged  or  excessive  HPA-axis  activity  following  chronic
stress  can  exceed  an  individual’s  allostatic  load  and  may
subsequently  result  in  the  development  of  psychiatric  and
somatic  disorders  (Juster  et  al.,  2010).  Indeed,  exposure  to
traumatic  stress  is  a  major  risk  factor  for  many  psychiatric
disorders,  including  schizophrenia,  bipolar  disorder,  major
depressive  disorder,  and  anxiety  disorders  (Heim  et  al.,
2008).
Corticosteroids  bind  to  two  receptors  in  the  brain:
the  mineralocorticoid  receptor  (MR)  and  the  glucocorticoid
receptor  (GR).  These  receptors  operate  in  a  complemen-
tary  fashion  to  regulate  HPA-axis  activity  (de  Kloet,  2013;
Harris  et  al.,  2013).  Activation  of  the  GR  and  MR  triggers  a
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ignalling  pathway  involving  a  cascade  of  cellular,  immuno-
ogical  and  physical  changes  via  genomic  transcriptional
egulation  (Joëls  et  al.,  2009).  Whereas  the  GR  is  expressed
hroughout  the  brain,  the  MR  is  predominately  expressed  in
imbic  areas  such  as  the  hippocampus  and  amygdala  (Patel
t  al.,  2001;  Reul  and  de  Kloet,  1985;  Seckl  et  al.,  1991).
n  the  hippocampus,  MRs  are  co-localized  with  GRs  (Patel
t  al.,  2001).  Compared  to  the  GR,  corticosteroids  have  a  10-
old  higher  MR  afﬁnity  (Grossmann  et  al.,  2004;  Rupprecht
t  al.,  1993).  These  high-afﬁnity  characteristics  result  in
 high  MR  occupancy  rate  even  under  basal  (non-stressful)
onditions  in  order  to  maintain  low  basal  corticosteroid  lev-
ls  through  negative  feedback  (de  Kloet  and  Reul,  1987;
eul  and  de  Kloet,  1985).  In  contrast,  full  GR  occupancy  is
nly  reached  when  cortisol  concentrations  peak,  for  exam-
le  after  awakening  or  as  a  result  of  stress.  It  is  therefore
ot  surprising  that  the  GR  has  dominated  endocrine  stress
esearch.  With  regard  to  the  relation  between  the  MR  and
R,  both  receptors  have  complementary  roles  in  the  reg-
lation  of  HPA-axis  functionality  (de  Kloet  et  al.,  2007).
n  contrast  to  the  MR,  the  genomic  GR  facilitates  recov-
ry  and  adaptation  and  normalizes  brain  functioning  some
ours  after  stress  exposure  when  corticosteroid  levels  have
eturned  to  baseline  due  to  negative  feedback  (Joëls  et  al.,
012).  The  high  afﬁnity  of  MR  for  cortisol  has  been  reason  to
elieve  that  the  MR  mainly  facilitated  GR  functionality  by
inding  cortisol  rather  than  having  an  independent  role  in
tress  reactivity.  Pioneering  in-depth  studies  over  the  past
9 F.  ter  Heegde  et  al.
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Box  1  The  membrane-bound  MR
Initial  evidence  for  the  existence  of  a  membrane-
bound  MR  was  found  in  an  electrophysiological  study  of
hippocampal  neurons  in  which  corticosterone  rapidly
and  reversibly  altered  signalling  in  pyramidal  CA1
neurons  (Karst  et  al.,  2005).  High  levels  of  corticoste-
rone  increased  the  frequency  of  miniature  excitatory
postsynaptic  potentials  (mEPSC).  The  MR  agonist  aldos-
terone  but  not  the  GR  agonist  RU28362  increased
mEPSC  frequency,  and  these  effects  could  be  blocked
with  the  MR  antagonist  spironolactone.  Moreover,  BSA-
corticosterone,  unable  to  pass  the  cell  membrane,
increased  hippocampal  signalling,  whereas  the  trans-
lational  inhibitor  cyclohexidine  did  not  block  these
corticosterone  effects.  Qiu  et  al.  (2010)  demonstrated
that  the  MR  was  present  in  synaptosomal  fractions
and  in  puriﬁed  membranes  of  the  hippocampus.  Subse-
quently,  Prager  et  al.  (2010)  found  MR  to  be  expressed
in  the  lateral  amygdala  at  both  nuclear  and  extranu-
clear  sites  including  presynaptic  terminals,  neuronal
dendrites,  and  dendritic  spines.  Furthermore,  MR
expression  was  present  on  post-synaptic  membrane
densities  of  excitatory  neurons.  This  anatomical  loca-
tion  of  the  membrane-bound  MR  enables  this  receptor
to  regulate  synaptic  plasticity.  Also,  a  membrane-
bound  MR  in  the  basolateral  amygdala  rapidly  enhances
glutamatergic  transmission  yet,  unlike  in  the  hip-
pocampus,  this  enhancement  is  long-lasting  (Karst
et  al.,  2010).  Taken  together  these  studies  provide
evidence  for  a  membrane-bound  MR  responsible  for
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wo  decades  have  revealed  signiﬁcant  insight  how  the  brain
R  operates  in  the  processing  of  stressful  information.
MR-related  research  was  accelerated  by  the  ﬁnding  that
he  MR  exerts  rapid  effects  on  neurotransmission  and  synap-
ic  plasticity  in  the  hippocampus  and  the  amygdala  under
tressful  circumstances  (Karst  et  al.,  2005,  2010).  These
apid  and  non-genomic  effects  of  cortisol  appear  to  be  medi-
ted  by  MRs  located  at  the  plasma  membrane  rather  than
enomic  receptors  (Groeneweg  et  al.,  2012;  Karst  et  al.,
010).  The  discovery  of  these  stress-responsive  membrane
Rs  in  the  brain  has  put  the  MR  forward  as  an  important
tress  moderator.  Several  reviews  have  come  out  over  the
ast  decade  focusing  on  the  role  of  the  MR  in  HPA-axis
ctivity  and  behaviour  (Berardelli  et  al.,  2013;  Joëls  et  al.,
008;  Reul  et  al.,  2000).  Therefore,  we  review  the  current
vidence  for  a  role  of  the  MR  in  stress  resilience  and  vul-
erability  for  psychiatric  disorders  and  focus  on  the  existing
linical  literature.  First,  we  will  brieﬂy  discuss  the  structure
nd  function  of  the  MR.  Then,  we  will  summarize  preclinical
nd  clinical  studies  examining  the  role  of  the  MR  in  (i)  basal
nd  stress-induced  HPA-axis  activity  and  (ii)  stress  appraisal
nd  memory  formation.  Subsequently,  we  will  outline  how
he  MR  may  play  a  role  in  stress  resilience  in  the  context  of
sychiatric  disorders.  In  addition,  we  will  discuss  how  sex-
ependency  may  inﬂuence  the  effects  of  the  MR.  Finally,
e  outline  how  future  research  targeting  the  MR  may  be
ntegrated  to  more  directly  beneﬁt  psychiatry.
. MR  structure and function
.1.  MR  function
he  MR  has  received  the  most  attention  in  its  role  as
 genomic  cytoplasmic  nuclear  transcription  factor.  Upon
orticosteroid  binding,  the  receptor—ligand  MR  complex
ranslocates  to  the  nucleus,  affecting  transcription  of  vari-
us  genes  including  growth  factors,  cell-adhesion  molecules
nd  neuropeptides  (Gekle  et  al.,  2013;  Meinel  et  al.,  2014;
ascual-Le  Tallec  and  Lombès,  2005).  Due  to  the  high  corti-
osteroid  afﬁnity,  most  genomic  MRs  remain  occupied  during
rough  levels  of  the  diurnal  HPA  cycle,  compared  to  10%
f  the  total  GR  population  (de  Kloet  and  Reul,  1987).  As
 result,  the  genomic  MR  is  capable  of  setting  the  threshold
or  HPA-axis  activation.
However,  cortisol  has  rapid  effects  incompatible  with
enomic  pathways  (for  a  review  see  Tasker  et  al.,  2006).
lready  from  functional  behavioural  studies,  cortisol  was
ound  to  acutely  inﬂuence  risk  assessment  (Mikics  et  al.,
005).  Recent  breakthroughs  have  shown  that,  in  addi-
ion  to  the  slower  genomic  effects,  the  MR  is  capable  of
apidly  responding  to  elevated  cortisol  levels  which  has  been
scribed  to  a  membrane-bound  MR  (see  Box  1)  (Groeneweg
t  al.,  2012;  Karst  et  al.,  2005,  2010).  In  support,  the  MR  ago-
ist  aldosterone  exerts  rapid  effects  on  the  HPA  axis  which
an  be  blocked  with  an  MR  antagonist  but  not  with  a  GR
ntagonist  (Atkinson  et  al.,  2008).  Furthermore,  cortisol  has
 reduced  afﬁnity  for  the  membrane-bound  MR  compared  to
he  genomic  MR,  with  10-  to  20-fold  higher  corticosterone
oncentrations  required  to  increase  hippocampal  signalling
ia  the  membrane-bound  MR  (Karst  et  al.,  2005).  In  this
ontext,  the  membrane-bound  MR  may  process  the  rapid
1
D
gfacilitating  fast  synaptic  transmission.
ffects  of  stress-induced  increased  corticosteroid  levels  and
ulses  and  inﬂuence  the  appraisal  of  an  acute  stressful
ituation  in  the  initial  phase  (Joëls  et  al.,  2008).  In  con-
rast,  the  genomic  MR  is  thought  to  have  a  more  regulatory
unction  and  determines  HPA-axis  sensitivity  and  the  thresh-
ld  for  stress  reactivity.  This  discovery  of  a  non-genomic
embrane-associated  receptor  in  addition  to  the  ‘classic’
enomic  receptor  has  increased  the  importance  of  the  MR
s  a  determinant  of  stress  susceptibility.
.2.  The  MR  gene  (NR3C2)
he  MR  is  encoded  by  NR3C2  located  on  chromosome  4  where
t  spans  approximately  450  kB  and  consists  of  10  exons  and
as  ﬁrst  cloned  by  Arriza  et  al.  (1988). The  ﬁrst  two  exons
  and  1  are  untranslated  and  result  in  two  different  mRNA
soforms.  Exons  3  and  4  code  for  the  DNA  binding  domain,
xons  5—8  and  the  ﬁrst  part  of  exon  9  code  for  the  ligand
inding  domain  (Pascual-Le  Tallec  and  Lombès,  2005).  Sev-
ral  mRNA  splice  variants  have  been  described.  In  humans,
he  complete  MR  protein  is  composed  of  983  amino  acids  and
R  diversity  results  from  two  translation  start  sites  which
ead  to  the  107  kDa  MR-A  and  the  15  amino  acid  smaller
05.4  kDa  MR-B  (Pascual-Le  Tallec  et  al.,  2004).
Exonic  sequencing  of  NR3C2  in  ﬁfty  individuals  from  the
utch  population  resulted  in  the  identiﬁcation  of  several  sin-
le  nucleotide  polymorphisms  (SNPs)  (van  Leeuwen,  2010).
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Figure  1  The  human  MR-gene  and  two  major  haplotype  blocks.  Introns  are  indicated  in  grey  and  the  exons  (1b,  1a  and  2—9)  in
colour. P2  and  P1  are  promoter  regions.  UTR  =  untranslated  region.  In  the  5′ region  three  common  functional  haplotypes  have  been
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Tdescribed, based  on  two  SNP,  MR-2C/G  (rs2070951)  and  MRI180
present based  on  rs5534  and  rs2871  from  which  three  (other)  com
are indicated.
Haplotype  analyses  showed  that  two  common  haplotype
blocks  exist:  one  in  the  5′ region  (based  on  rs2070951  and
rs5522)  and  one  in  the  3′ region  (based  on  rs5534  and  rs2871)
(Fig.  1).
In  haplotype  block  1,  MR-2C/G  (rs2070951)  is  located
2  nucleotides  before  the  translation  site  of  exon  2,  and
MRI180V  (rs5522)  is  located  within  exon  2  (Table  1).  Both
SNPs  affect  in  vitro  transactivation  by  altering  either  MR
expression  or  functionality.  MRI180V  substitutes  isoleucine
(A)  for  valine  (G)  in  the  N-terminal  of  the  MR  protein  and
in  vitro  testing  shows  that  the  Val-allele  results  in  a  mild
loss  of  function  compared  to  the  Iso-allele  (DeRijk  et  al.,
2006;  van  Leeuwen  et  al.,  2011).  The  MR-2C/G  SNP  is  located
outside  the  MR  coding  region  but  inside  a  Kozac  translation
regulatory  sequence  which  regulates  MR  transcription.  In
vitro,  the  C-allele  results  in  increased  MR  expression  (van
Leeuwen  et  al.,  2010a).  MRI180V  and  MR-2C/G  are  in  low
linkage  disequilibrium  (r2 =  0.11),  and  the  combination  of
these  2  SNPs  results  theoretically  in  4  MR  haplotypes  of
which  three  are  common  in  the  general  population  while
haplotype  4  has  hardly  been  observed  (Table  1)  (DeRijk
et  al.,  2008).  These  haplotypes  also  inﬂuence  MR  func-
tionality  and  are  frequently  used  to  investigate  the  effects
of  common  and  functional  genetic  MR  variation  in  clinical
n
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Table  1  Characteristics  of  MR-2C/G  (rs2070951)  and  MRI180V  (rs
which the  majority  of  clinical  studies  investigating  genetic  MR  vari
A:  SNPs
SNP  Minor  allele  frequency  (%)  Homo
MR-2C/G  rs2070951  ±50  (C)  ±25%
MR-II80V rs5522  ±12  (G)  ±1—2
B: MR  haplotypes
Frequency  (%)  MR-2C/G  
GA  Haplotype  50  G  
CA haplotype  35  C  
CG haplotype  12  C  s5522).  In  the  3 region  (exon  9),  a  second  haplotype  block  is
 haplotypes  can  be  constructed.  Frequencies  of  the  haplotypes
tudies  (Klok  et  al.,  2011b;  van  Leeuwen  et  al.,  2011).  Of
hese  haplotypes,  in  vitro  the  GA  haplotype  (haplotype  ‘1’)
hows  a  signiﬁcant  lower  maximal  transactivation  and  a
ower  protein  expression  compared  to  the  CA  and  CG  haplo-
ype  (haplotypes  ‘2’  and  ‘3’,  see  Table  1).  Additional  testing
f  the  promoter  region  of  the  three  haplotypes  in  vitro
evealed  different  activities  under  basal  non-stimulated
onditions  with  the  GA  haplotype  (haplotype  ‘2’)  having  the
ighest  activity  and  the  CG  haplotype  (haplotype  ‘3’)  the
owest  (Klok  et  al.,  2011b).  In  addition  to  these  three  haplo-
ypes,  MR  diplotypes  (speciﬁc  combinations  of  haplotypes)
ould  display  even  additional  unexpected  regulations  and
ctivities  (Fig.  2).  Taken  together,  loss  of  function,  changes
n  translational  activity  and  different  promoter  activities  all
ontribute  to  high  variability  of  in  vivo  MR-expression  and
ctivity  with  regard  to  these  two  exon  2  SNPs.
.3.  MR  expression
he  MR  is  expressed  in  different  tissues  including  the  kid-
ey,  adipose  tissue,  endothelium,  epithelial  lining  cells  and
acrophages.  Classically,  the  MR  is  expressed  in  epithelial
issue  of  the  kidney  (Martinerie  et  al.,  2013).  In  the  kidney,
ldosterone  (part  of  the  renin—angiotensin—aldosterone
5522)  (A)  and  the  three  derived  functional  haplotypes  (B)  on
ation  are  based.
zygous  minor  allele  carriers  (%)  MR  functionality  in  vitro
 ↓  for  G-allele  carriers
%  ↓  for  G-allele  carriers
MRI80V  MR  functionality
A  Reference
A  ↑  expression,  transactivation  and
activity  (Klok  et  al.,  2011b;  van
Leeuwen  et  al.,  2011)
G  ↑  expression  and  transactivation  (van
Leeuwen  et  al.,  2011),  no  changes  in
activity  (Klok  et  al.,  2011b)
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Figure  2  Distribution  of  MR  diplotypes  (combination  of  MR
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3.1.  Preclinical  studiesaplotypes)  based  on  rs5522  (and  rs2070951)  in  a  population-
ased cohort  (665  healthy  individuals)  (Unpublished  data).
ystem)  is  the  main  endogenous  MR  ligand  with  a  high
R  afﬁnity  due  to  the  activity  of  the  kidney  enzyme  11-
eta  hydroxysteroid  dehydrogenase  type  2  (11-HSD2)  which
atabolizes  cortisol  into  the  inactive  metabolite  cortisone.
ype  1  11-HSD  is  expressed  throughout  the  brain  where  it
s  responsible  for  the  regeneration  of  active  cortisol  from
ts  inactive  11-keto  derivate  (for  a  review  on  the  opposing
unctions  of  the  11-HSD  isoforms  see  Wyrwoll  et  al.,  2011)
ldosterone  increases  retaining  of  sodium  and  water  in  the
enal  collecting  duct  of  the  kidney  (Carey  and  Padia,  2008).
onversely,  aldosterone  levels  in  the  brain  are  very  low
over  100-fold)  due  to  the  absence  of  the  cortisol  convert-
ng  enzyme  aldosterone  synthase  (Ferrari,  2010).  Therefore,
ortisol  is  the  main  ligand  for  the  brain  MR,  especially  in
imbic  brain  regions.  Moreover,  extensive  MR  expression  has
een  described  in  adipose  tissue  with  a  role  in  adipose  tis-
ue  development,  metabolism  as  well  as  the  production  of
ro-inﬂammatory  mediators  (Marzolla  et  al.,  2012).  In  the
eart,  MR-expression  in  macrophages  was  found  to  be  an
mportant  factor  contributing  to  ongoing  inﬂammation  after
 myocardial  infarct  (Rickard  et  al.,  2009).
MR  expression  in  the  brain  is  largely  restricted  to  neurons
n  limbic  areas  such  as  the  hippocampus  and  amygdala.  This
ontrasts  with  the  GR  which  is  expressed  throughout  the
rain  (Reul  and  de  Kloet,  1985).
MR  expression  has  direct  protective  effects  at  a  neu-
onal  level.  MR  overexpression  reduced  neuronal  cell  death
fter  transient  cerebral  global  ischaemia  (Lai  et  al.,  2007),
nd  this  effect  was  reversed  with  MR  antagonists  (Macleod
t  al.,  2003).  Similarly,  cell-lines  overexpressing  the  MR
esult  in  higher  neuronal  survival  which  could  be  reversed
y  knocking  down  the  MR  (Munier  et  al.,  2012).  Conversely,
ransgenic  mice  lacking  MR  show  decreased  density  of  gran-
le  cells  in  the  hippocampus  and  a  signiﬁcant  reduction  of
ranule  cell  neurogenesis  (Berger  et  al.,  2006).  Moreover,  MR
lockade  by  spironolactone  dose-dependently  increased  cell
eath  (Crochemore  et  al.,  2005).  Therefore,  both  in  vitro
nd  in  vivo  studies  indicate  that  the  MR  is  essential  to
aintain  neuronal  integrity  and  promotes  neurogenesis.
oreover,  MR  blockade  accentuated  GR-mediated  apoptosis
fter  co-administration  with  dexamethasone  (Crochemore
S
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t  al.,  2005).  Thus,  the  MR  may  also  have  an  anti-apoptotic
nd  regulatory  role  in  preventing  GR-mediated  apopto-
is.  An  interesting  phenomenon  is  the  fact  that  in  Brown
orway  rats  which  display  long  healthy  ageing,  there  is  an
ncreased  constitutive  activation  of  the  MR  (Marissal-Arvy
t  al.,  2000).  In  these  rats,  a  relation  was  found  between
 gain-of-function  mutation  in  the  MR  and  the  effects  of
drenalectomy  (Marissal-Arvy  et  al.,  2004).
Together,  these  neuroprotective  properties  may  provide  a
eurobiological  basis  for  the  putative  pro-resilience  effects
f  the  MR.  Downregulation  of  the  MR  in  the  hippocampus  and
mygdala  could  affect  neuronal  integrity,  thereby  disrupting
imbic  system  outputs  to  the  hypothalamus  and  increasing
he  risk  for  stress-related  psychiatric  disorders.
One  important  factor  affecting  MR  expression  is  age.
ncreased  age  is  associated  with  decreased  MR  expression,
esulting  in  a  loss  of  HPA-axis  inhibition  and,  consequently,
 chronic  elevation  of  cortisol  levels  (Giordano  et  al.,  2005;
euser  et  al.,  2000;  Van  Eekelen  et  al.,  1991). These  chron-
cally  elevated  cortisol  levels  may  play  a  role  in  the  reduced
ognitive  functioning  seen  in  the  elderly  (Yau  and  Seckl,
012).  Animal  studies  support  the  inverse  relation  between
ge  and  MR  expression.  Aged  dogs  showed  a  decrease  in
eptal  and  hippocampal  MR  levels  accompanied  by  elevated
asal  ACTH  and  cortisol  levels  (Reul  et  al.,  1991;  Rothuizen
t  al.,  1993),  and  ageing  in  rats  decreased  MR  mRNA  expres-
ion  in  the  hippocampus  and  hypothalamus  paired  with
 progressively  attenuated  but  prolonged  corticosterone
tress  response  (Van  Eekelen  et  al.,  1991;  Workel  et  al.,
001).  It  is  currently  unclear  whether  age-related  changes
n  MR  expression  inﬂuence  the  risk  for  stress-related  psy-
hiatric  disorders.  Moreover,  GR  expression  —  and  therefore
lso  the  GR/MR  balance  —  may  also  play  a  role  in  age-related
ffects  of  the  HPA-axis.  Indeed,  age-related  changes  in  GR
RNA  levels  have  been  found  in  the  human  brain  (Perlman
t  al.,  2007).  Nevertheless,  age-induced  decreases  in  MR
xpression  were  positively  correlated  to  age-dependent
mpairments  in  spatial  memory  (Yau  et  al.,  2002a).  Inter-
stingly,  amitriptyline  treatment  in  young  rats  increased
ippocampal  MR,  but  not  GR,  expression  and  simultaneously
ncreased  spatial  memory  whilst  the  same  treatment  had
o  signiﬁcant  effect  in  aged  rats  (Yau  et  al.,  1995).  This
upports  the  hypothesis  of  an  age-induced  decrease  in  MR
unctionality  which  has  implications  for  the  use  of  MR  ago-
ists  in  the  treatment  of  elderly  patients.  Furthermore,
ong-term  treatment  with  amitriptyline  in  relatively  young
ats  (16  months  old)  until  they  were  aged  (24  months)  pre-
ented  cognitive  impairments  and  reduced  anxiety-related
ehaviours  in  aged  rats  (Yau  et  al.,  2002b).  Together,  these
ata  suggest  that  MR  expression  is  vital  for  neuronal  survival
nd  an  adequate  HPA-axis  functionality.  Reduced  MR  expres-
ion  may  therefore  affect  an  individual  resilience  potential
nd  increase  the  risk  for  detrimental  outcomes  after  stress
xposure.
. The MR and HPA-axis activityeveral  preclinical  studies  have  investigated  the
nvolvement  of  the  MR  in  HPA-axis  functionality.  First,
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pharmacological  studies  using  MR  antagonists  have  demon-
strated  a  role  for  the  MR  in  basal  HPA  axis  activity  (Bradbury
et  al.,  1991;  Ratka  et  al.,  1989).  Moreover,  mice  lacking
forebrain  MR  display  enhanced  and  prolonged  cortico-
sterone  levels  in  response  to  restraint  stress,  indicating
that  forebrain  MR  may  speciﬁcally  inhibit  stress-induced
HPA-axis  activity  (Ter  Horst  et  al.,  2012b).  In  these  mice,
basal  corticosterone  levels  were  only  slightly  elevated
(Ter  Horst  et  al.,  2012b)  or  did  not  signiﬁcantly  differ
(Berger  et  al.,  2006).  Apparently,  loss  of  the  forebrain
MR  leads  to  increased  stress-induced  corticosterone  levels
but  does  not  affect  basal  levels.  In  contrast,  overexpress-
ion  of  MR  in  the  forebrain  was  associated  with  similar
basal  and  stress-induced  HPA  axis  activity  in  male  mice
(Lai  et  al.,  2007;  Rozeboom  et  al.,  2007),  but  in  female
transgenic  mice,  restraint  stress  resulted  in  a  moderate
suppression  of  corticosterone  levels  (Rozeboom  et  al.,
2007).  Moreover,  overexpression  of  the  MR  in  the  baso-
lateral  amygdala  resulted  in  lower  stress-induced  plasma
corticosterone  levels  in  MR-overexpressing  animals  with  no
effect  on  basal  corticosterone  levels  (Mitra  et  al.,  2009).
Interestingly,  overexpression  of  forebrain  MR  rescued  the
overshoot  in  HPA-axis  activity  seen  in  mice  with  a  reduced
GR  expression.  The  combination  of  high  forebrain  MR
and  an  overall  reduced  GR  expression  restored  HPA-axis
activity  under  stressful  conditions,  implying  that  in  the
case  of  reduced  GR  activity,  an  increase  in  MR  activity
functions  to  normalize  stress-induced  HPA-axis  activity
providing  evidence  that  the  two  receptors  work  in  a
complementary  fashion  to  promote  an  adequate  coping
style  (Harris  et  al.,  2013).  Also,  the  selective  MR  antagonist
spironolactone  (but  not  a  GR  antagonist)  could  reverse
blunting  of  the  endocrine  stress  response  after  repeated
restraint  stress  in  rats  (Cole  et  al.,  2000).  However,  not
all  studies  are  consistent.  For  example,  male  and  female
mice  lacking  the  MR  in  the  entire  limbic  system  showed
normal  corticosterone  levels  at  circadian  trough  and  peak
as  well  as  after  40  min  of  restraint  stress  (Berger  et  al.,
2006).
In  rodents,  studies  show  that  the  relation  between  MR
expression  and  stress  reactivity  is  bidirectional  in  that
stress  exposure  can  also  affect  MR  expression.  These  effects
appear  to  be  dependent  on  the  duration  of  the  stressor.
Acute  stress  increased  hippocampal  MR  expression  which
peaked  after  24  h  and  subsequently  decreased  over  a  period
of  48  h  (Gesing  et  al.,  2001).  This  increase  was  found  to  be
functional  in  restraining  the  HPA  axis.  Even  after  a  single
bout  of  physical  exercise,  a  decrease  in  hippocampal  MR
expression  was  observed  within  30  min  (Chang  et  al.,  2008).
These  results  show  that  MR  expression  is  highly  dynamic
which  has  important  consequences  at  least  for  neuroen-
docrine  control.  In  contrast,  chronic  unpredictable  stress
caused  a  20%  decrease  in  hippocampal  MR  mRNA  compared
to  a  control  group  (Lopez  et  al.,  1998),  and  chronic  cortico-
sterone  administration  reduced  hippocampal  MR  but  not  GR
expression  (Wu  et  al.,  2013).
Together,  even  though  results  of  rodent  studies  are  not
completely  consistent,  the  majority  of  rodent  studies  shows
that  MR  effects  particularly  emerge  under  stressful  circum-
stances.  In  response  to  stress,  increased  MR  expression  is
associated  with  a  blunted  endocrine  stress  response.  Since
genomic  MRs  are  substantially  occupied  under  non-stress
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onditions,  non-genomic  MRs  may  be  involved  in  regulation
f  the  cortisol  stress  response.
.2.  Clinical  studies
.2.1.  Basal  HPA-axis  activity
linical  studies  investigating  the  relation  between  MR  func-
ionality  and  HPA-axis  activity  have  recently  emerged  and
omplement  the  existing  preclinical  literature  (DeRijk  et  al.,
011).  The  majority  of  these  studies  have  focused  on  com-
on  and  functional  genetic  variation  in  the  MR  based  on
s5522  and  rs2070951  (Table  1 and  Fig.  1).
With  regard  to  basal  HPA-axis  activity,  G-carriers  of
he  MR-2C/G  allele  (rs2070951)  display  higher  basal  corti-
ol  levels  accompanied  by  an  increased  cortisol  awakening
esponse  (CAR)  (Muhtz  et  al.,  2011).  Conversely,  C-carriers
ave  lower  basal  cortisol  levels  (Kuningas  et  al.,  2007)  and
n  attenuated  CAR  (Klok  et  al.,  2011c).  Consistent  with
hese  studies,  MR  haplotypes  containing  the  C-allele  of
s2070951  (the  CA  and  CG  haplotype,  see  Table  1)  are  asso-
iated  with  increased  MR  expression  (Klok  et  al.,  2011c;  van
eeuwen  et  al.,  2011).  Thus,  in  C-allele  carriers,  a  higher  MR
xpression  may  enhance  tonic  inhibition  and  result  in  lower
asal  cortisol  levels.  However,  not  all  studies  have  shown
onsistent  results.  In  a  cohort  of  218  healthy  volunteers,
o  signiﬁcant  effect  of  rs5522  and  rs2070951  were  found  on
he  CAR  (van  Leeuwen  et  al.,  2010b).  Nevertheless,  follow-
ng  0.25  mg  dexamethasone  administration,  a  sex-speciﬁc
odulation  suppression  was  found  in  this  study  for  rs5522
blunted  suppression  in  homozygous  male  A-carriers)  and
s2070951  (enhanced  female  suppression  and  impaired  male
uppression  in  G-carriers),  suggesting  that  MR  effects  may  be
ex-dependent  and  become  visible  under  challenging  (dexa-
ethasone)  conditions  (see  Section  6).
.2.2.  Stress-induced  HPA-axis  activity
everal  clinical  studies  have  investigated  whether  MR
ffects  are  also  present  following  stress  exposure.  In  a  study
f  166  school  teachers,  the  CA  MR  haplotype  was  associated
ith  an  increased  endocrine  stress  response  as  measured
y  ACTH  and  both  blood  and  saliva  cortisol  levels  (van
eeuwen  et  al.,  2011) (Table  1).  Increased  stress  reactivity
as  accompanied  by  lower  perceived  stress  levels.  In  con-
rast,  GA  haplotype-carriers  displayed  a  blunted  endocrine
tress  response.  However,  not  all  studies  have  found  signiﬁ-
ant  effects  for  these  two  SNPs  on  stress  reactivity.  First,  no
igniﬁcant  effects  of  rs5522  and  rs2070951  were  found  on  the
ortisol  stress  response  in  adolescents  (Bouma  et  al.,  2011).
he  effects  of  haplotypes  were  not  investigated  in  this  study.
econd,  the  I180V  SNP  (rs5522)  did  not  signiﬁcantly  inﬂuence
tress-induced  cortisol  levels  in  64  healthy  individuals  (Ising
t  al.,  2008),  and  the  rare  CG  haplotype  (largely  driven  by
180V)  did  also  not  alter  the  endocrine  stress  response  in  the
bove  mentioned  high  school  teacher  cohort  (van  Leeuwen
t  al.,  2011).  In  contrast,  in  110  male  twins,  Val-carriers
f  I180V  consistently  displayed  an  increased  cortisol  stress
esponse  after  repeated  exposure  to  the  Trier  Social  Stress
est  (DeRijk  et  al.,  2006).  Discrepancies  across  these  I180V
tudies  should  be  interpreted  in  light  of  the  relatively  small
inor  allele  frequency  of  rs5522  (12%  frequency)  (Table  1),
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nd  larger  sample  sizes  may  be  required  to  detect  consistent
nd  meaningful  differences.
Interestingly,  stress-related  effects  of  genetic  MR  varia-
ion  are  not  limited  to  the  endocrine  system.  Both  the  GA
aplotype  (van  Leeuwen  et  al.,  2011)  and  rs5522  (DeRijk
t  al.,  2006)  inﬂuenced  stress-induced  heart  rate  levels,
ndicating  that  MR  SNPs  can  inﬂuence  the  autonomic  stress
esponse.  Another  illustration  of  the  far-reaching  effects  of
R  functionality  is  an  fMRI  study  in  which  Val-carriers  of
he  MRI180V  SNP  showed  a  greater  threat-related  amygdala
eactivity  (Bogdan  et  al.,  2012).  In  this  study,  childhood
eglect  selectively  increased  amygdala  reactivity  in  Iso-
arriers,  suggesting  that  the  impact  of  traumatic  stress  on
he  brain  is  moderated  by  genetic  variation  in  the  MR.
.2.3.  Drug-induced  HPA-axis  activity
harmacological  studies  have  also  pointed  to  a  pivotal  role
f  the  MR  in  regulating  HPA-axis  activity.  First,  MR  antago-
ists  such  as  caneroate  (Arvat  et  al.,  2001;  Wellhoener  et  al.,
004)  and  spironolactone  (Cornelisse  et  al.,  2011;  Deuschle
t  al.,  1998;  Otte  et  al.,  2007;  Young  et  al.,  1998)  increase
asal  cortisol  levels.  Because  ACTH  levels  are  generally  not
ffected,  this  effect  is  probably  the  result  of  an  altered
PA-axis  threshold.  Chronic  MR  antagonism  with  caneroate
or  28  days  yielded  similar  results  with  increased  basal
ortisol  levels  but  no  changes  in  ACTH  levels  (Berardelli
t  al.,  2010).  Vice  versa,  ﬂudrocortisone,  which  activates
oth  the  GR  and  MR  but  has  a  much  higher  MR  afﬁnity
Grossmann  et  al.,  2004),  inhibits  the  HPA-axis  and  subse-
uently  decreases  basal  cortisol  levels  (Otte  et  al.,  2003a).
n  this  study,  metyrapone  (which  inhibits  the  production  of
ndogenous  cortisol)  was  co-administered  to  minimize  the
mpact  of  basal  endogenous  cortisol  secretion  and  to  ensure
ufﬁcient  reactivity  of  the  otherwise  substantially  occupied
R.  Effects  of  ﬂudrocortisone  on  the  HPA-axis  activity  via
R  activation  were  considered  unlikely  as  ﬂudrocortisone
oes  not  suppress  morning  cortisol  levels,  a  process  which
s  mainly  GR-related  (Otte  et  al.,  2003a).  Furthermore,
udrocortisone  inhibits  HPA-axis  activity,  in  both  healthy
ontrols  and  depressed  patients,  regardless  of  whether  basal
ndogenous  cortisol  secretion  is  inhibited  with  metyrapone
Buckley  et  al.,  2007;  Wingenfeld  et  al.,  2014).  This  suggests
hat,  even  though  the  MR  is  largely  occupied  during  circadian
adir  trough  levels,  further  MR  activation  is  still  possible
fter  administration  of  an  exogenous  MR  agonist.  Extrapo-
ating  these  ﬁndings  to  the  ﬁeld  of  stress  would  suggest  that
R-mediated  modulation  of  HPA-axis  activity  is  still  possible
uring  stress  exposure.  In  support,  stress-induced  increases
n  cortisol  after  the  Trier  Social  Stress  Test  are  enhanced
fter  administration  of  the  MR  antagonist  spironolactone
Cornelisse  et  al.,  2011).
It  is  important  to  notice  that  pharmacological  manipu-
ation  of  the  MR  appears  to  be  age-dependent.  First,  MR
ctivation  with  ﬂudrocortisone  induces  a  stronger  cortisol
ecrease  in  younger  individuals  compared  to  older  sub-
ects,  suggesting  an  impaired  MR-related  negative  feedback
Otte  et  al.,  2003b).  Similarly,  administration  of  the  MR
ntagonist  canrenoate  results  in  stronger  HPA-axis  activa-
ion  in  young  individuals  compared  to  older  ones  (Giordano
t  al.,  2005).  These  studies  are  consistent  with  age-related
ffects  on  MR  expression  levels  (see  Section  2.3).  Therefore,
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ge-induced  reductions  of  MR  expression  may  lead  to  a  more
ctive  but  less  dynamic  HPA-axis  which  could  subsequently
isproportionally  increase  the  risk  for  stress-related  disor-
ers.  However,  studies  linking  age  and  MR  functionality  in
he  context  of  psychiatric  disorders  are  lacking.
.3.  Summary
n  summary,  preclinical  and  clinical  studies  point  to  a  role
or  the  MR  in  basal  and  stress-induced  HPA-axis  activity.
hus,  MR  functionality  is  probably  important  for  an  adap-
ive  and  dynamic  HPA-axis.  The  dampening  MR  effect  on
PA-axis  activity  under  stressful  conditions  may  be  the
esult  of  an  excitatory  threshold  of  hippocampal  MRs  act-
ng  on  inhibitory  hypothalamic  interneurons.  Subsequently,
tress-induced  increases  in  corticosteroids  may  strengthen
nhibition  and  result  in  a  blunted  endocrine  stress  response.
owever,  clinical  studies  suggest  that  the  MR  can  also  affect
asal  cortisol  levels.  Moreover,  clinical  studies  also  indicate
hat  an  altered  MR  expression  and/or  functionality  is  associ-
ted  with  changes  in  drug-induced  cortisol  levels.  However,
he  evidence  is  inconsistent  across  studies  and  not  all  stud-
es  have  found  signiﬁcant  MR  effects.  Several  factors  may
xplain  discrepancies  across  studies,  including  (i)  differ-
nces  in  sex  and  age  (ii)  unaccounted  variation  by  traumatic
tress  exposure  and  a  history  of  psychiatric  disorders,  (iii)
ethodological  differences,  e.g.  in  the  applied  stress  test
nd  the  use  of  single  SNPs  or  haplotypes,  (iv)  relatively  small
ample  sizes.
. The MR and stress-related appraisal and
emory
ifferent  stages  of  memory  processing  in  the  brain  are  gen-
rally  distinguished:  encoding,  consolidation,  retrieval  of
he  memory,  and  ﬁnally,  reconsolidation.  Stress  can  (posi-
ively  or  negatively)  inﬂuence  all  of  these  memory  stages
ut  these  effects  depend  on  several  factors,  for  example
hether  stress  exposure  occurs  before  or  after  a  memory-
elated  process  and  the  interval  between  stress  and  testing
for  reviews  see  Joëls  et  al.,  2006;  Schwabe  et  al.,  2012).
or  memory  formation,  stress  exposure  prior  to  learning  can
ither  enhance  or  weaken  this  process  depending  on  the
ime  interval  between  the  stressor  and  learning  as  well  as
he  emotional  load  of  the  stressor.  Consolidation  is  typically
nhanced  by  stress,  whereas  stress  prior  to  retention  tests
enerally  impairs  memory  retrieval.  In  light  of  the  stress
ffects  on  memory,  suboptimal  HPA-axis  functionality  may
e  involved  in  memory  impairments  which  exist  in  several
sychiatric  disorders  (Wingenfeld  and  Wolf,  2011).
In  light  of  its  close  involvement  in  HPA-axis  activity  (see
ection  3),  a  role  for  the  MR  in  regulating  stress-related
earning  and  (fear)  memories  is  biologically  plausible.  Sev-
ral  lines  of  converging  evidence  have  implicated  the  MR  in
tress-related  memory  processes.  First,  the  MR  antagonist
pironolactone  impaired  long-term  potentiation  (LTP)  for-
ation  and  even  induced  long-term  depression  in  stressed
nimals  (Avital  et  al.,  2006).  In  contrast,  administration
f  the  GR  antagonist  RU38486  prior  to  stress  produced
 striking  LTP  facilitation  and  indicated  that  the  MR  and
R  exert  an  opposing  inﬂuence  on  hippocampal  plasticity.
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Moreover,  using  intracellular  recording  techniques,  MR
activation  induced  opposite  effects  to  the  GR  on  after-
hyperpolarization  of  rat  CA1  pyramidal  neurons  (Joëls  and
de  Kloet,  1990),  including  a  suppression  of  5-HT-induced
hyperpolarization  (Joëls  et  al.,  1991),  indicating  different
and  even  opposing  effects  on  neuronal  activation.
Second,  several  behavioural  rodent  studies  show  that
the  MR  is  involved  in  memory.  MR-overexpressing  mice
display  improved  spatial  memory  (Lai  et  al.,  2007)  and
enhanced  consolidation  of  non-spatial  memory  (Ferguson
and  Sapolsky,  2007).  In  contrast,  the  MR  antagonist  spirono-
lactone  reduced  context  fear,  indicating  that  the  MR  is
pivotal  for  contextual  memory  retrieval  and  formation
(Zhou  et  al.,  2011).  Conversely,  mice  lacking  limbic  MR
expression  show  impaired  learning  (Ter  Horst  et  al.,  2012a)
and  working  memory  deﬁcits  as  a  result  of  behavioural
perseverance  (Berger  et  al.,  2006).  Moreover,  MR  antag-
onists  directly  inﬂuence  the  spatial  learning  strategy  in
response  to  novelty  (Oitzl  and  de  Kloet,  1992;  Oitzl  et  al.,
1994).
Third,  studies  on  the  MR  antagonist  spironolactone  have
shown  that  the  MR  mediates  many  different  aspects  of
stress-related  memory  formation.  In  a  cohort  of  64  young
men,  administration  of  the  MR  antagonist  spironolactone
prior  to  stress  exposure  (but  not  prior  to  the  control  con-
dition)  resulted  in  short-term  working  memory  impairments
but  enhancement  of  long-term  memory  (Cornelisse  et  al.,
2011).  Thus,  MR  blockade  combined  with  increased  cortisol
levels  impairs  working  memory,  and  this  may  be  the  result
of  a  relative  increase  in  GR  binding.  In  addition,  spirono-
lactone  administration  prevented  stress-induced  increases
in  response  inhibition,  suggesting  a  role  for  the  MR  in
this  process  (Schwabe  et  al.,  2013a).  Similarly,  spironolac-
tone  also  prevented  stress-induced  and  MR-mediated  switch
from  hippocampus-based  learning  (explicit  knowledge)  to
striatum-based  learning  approach  (procedural)  which  is
needed  to  preserve  memory  performance  during  and  shortly
after  stress  (Schwabe  et  al.,  2013b).  In  support,  Val-
allele  carriers  of  the  I180V  SNP  —  associated  with  reduced
MR  functionality  —  showed  a  deﬁciency  in  stress-induced
reward  learning  (Bogdan  et  al.,  2010).  Thus,  a  decreased
MR  functionality  may  have  detrimental  effects  on  stress-
related  learning.  Consequently,  this  could  increase  the  risk
of  fear  generalization  as  is  commonly  found  in  anxiety
disorders.
The  MR  is  also  important  for  the  adequate  appraisal  of
stressful  situations.  This  effect  is  closely  related  to  the
effects  on  memory  because  both  processes  are  the  result
of  MR-related  learning  plasticity  (de  Kloet  et  al.,  1999;
Oitzl  et  al.,  1994).  After  appraisal  of  a  novel  situation,
an  appropriate  learning  strategy  is  selected  which  deter-
mines  memory  formation.  Subsequently,  formed  memories
will  inﬂuence  appraisal  in  future  stressful  situations.  As
such,  appraisal  and  memory  formation  function  in  a  comple-
mentary  fashion  to  ensure  an  adaptive  behavioural  response
when  faced  with  a  stressor.
The  MR  facilitates  stress  appraisal  by  an  appropriate
evaluation  of  contextual  inﬂuences.  For  example,  MR  antag-
onism  was  found  to  alter  search  patterns  in  the  Morris
water  maze  without  affecting  retention  times  per  se  (de
Kloet  et  al.,  1999;  Oitzl  et  al.,  1994).  Similarly,  mice  lack-
ing  the  forebrain  MR  showed  alterations  in  exploratory
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ehaviour  indicative  of  impaired  acquisition  of  novel
nformation  (Arp  et  al.,  2014).  Moreover,  these  mice  could
ot  distinguish  between  cue-related  and  context-related
reezing  in  a  fear  conditioning  test  (Brinks  et  al.,  2009).
hen  mice  are  exposed  to  stress  and  a  switch  to  stimulus-
esponse  learning  is  required,  pre-treatment  with  the  MR
ntagonist  RU28318  prevents  this  switch  (Schwabe  et  al.,
010;  Ter  Horst  et  al.,  2012b),  suggesting  a  role  for  the  MR
n  spatial  memory  formation  and  the  appraisal  of  novel  sit-
ations.  Moreover,  aggressive  behaviour  during  a  conﬂict  in
ats  for  violent  aggression  appeared  to  be  mediated  through
he  brain  MR  (Kruk  et  al.,  2004,  2013).  In  this  experimental
esign,  the  initial  corticosterone  response  facilitated  the
earning  of  aggressive  behaviour  in  a  MR-dependent  fash-
on.  This  is  a  lasting  effect  which  could  only  be  blocked
y  spironolactone  during  the  ﬁrst  aggressive  encounter  but
ot  during  a  follow  up  aggressive  encounter.  Together,  these
ata  suggest  that  the  MR  is  involved  in  appraisal  and  learning
f  long  lasting  behaviour.
A  recent  study  in  483  healthy  participants  showed  that
R3C2  variance  was  associated  with  negative  memory  bias,
specially  in  individuals  with  a  history  of  life  adversity
Vogel  et  al.,  2014).  Speciﬁcally,  this  interaction  was  sig-
iﬁcant  for  the  functional  exon  9  haplotype  block  (based
n  rs5534/rs2871),  but  not  for  the  exon  2  haplotype  block
rs5522/rs2070951).  Particularly,  homozygotic  A-carriers  of
s5534,  associated  with  increased  microRNA-induced  repres-
ion  of  MR  expression,  showed  a  signiﬁcant  increase  in
egative  memory  bias.  The  relation  between  impaired  reg-
lation  of  MR  expression  and  enhanced  memory  formation
or  sad  and  pessimistic  information  indicates  that  an  altered
R  functionality  can  negatively  inﬂuence  memory  forma-
ion  during  stressful  situations.  Together,  these  studies
nderscore  that  MR  functionality  is  important  for  contex-
ual  recognition  and  the  subsequent  correct  appraisal  of  a
tressful  situation.  In  this  context,  reduced  MR  activity  or
xpression  may  result  in  a suboptimal  assessment  of  a  stress-
ul  situation  and  increase  the  risk  for  dysfunctional  cortisol
egulation  and  persisting  fear  and  anxiety  symptoms  after
tress  exposure.
With  regard  to  the  MR  effects  of  stress  on  memory,  both
enomic  MRs  and  non-genomic  MRs  are  involved  (Chauveau
t  al.,  2010).  For  example,  the  protein  synthesis  inhibitor
nisomycin  was  unable  to  reverse  corticosterone-induced
emory  deﬁcits  in  young  rats  during  the  water  maze  task,
ndicating  that  cortisol-induced  impairment  of  long-term
emory  retrieval  is  regulated  via  non-genomic  pathways
Khaksari  et  al.,  2007).  In  this  study,  the  MR  antago-
ist  spironolactone  but  not  the  GR  antagonist  RU38486
as  able  to  reverse  this  effect.  Similarly,  a  study  using
SA-bound  corticosterone,  which  cannot  pass  the  cell  mem-
rane,  induced  memory  retrieval  deﬁcits  which  can  be
eversed  by  an  MR  antagonist  but  not  a  GR  antagonist  (Dorey
t  al.,  2011).  Therefore,  it  appears  that  the  membrane-
ound  MR  also  mediates  stress-induced  effects  on  memory
rocesses.
Even  though  this  paragraph  focused  on  stress-induced
earning  processes,  it  is  important  to  notice  that  the  MR
lso  affects  learning  strategies  under  non-stressful  circum-
tances.  For  example,  the  MR  is  required  for  an  optimal
patial  learning  strategy  in  the  circular  hole-board  test
nder  basal  conditions  (Arp  et  al.,  2014),  while  in  humans
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R  blockade  by  spironolactone  impaired  selective  attention
nder  non-stressful  conditions  (Otte  et  al.,  2007).  Further-
ore,  MR  stimulation  with  ﬂudrocortisone  improved  verbal
emory  in  both  healthy  controls  and  depressed  patients
Wingenfeld  et  al.,  2014).
Although  stress-induced  memory  formation  is  a  com-
lex  process,  several  studies  indicate  that  the  MR  plays
n  important  role  in  mediating  appraisal  as  well  as  mem-
ry  formation  and  retrieval.  Memory  formation  seems  to
e  enhanced  via  genomic  MRs,  whereas  retrieval  of  long-
erm  memory  during  acute  stress  seems  to  be  hampered
y  non-genomic  MRs.  It  may  be  hypothesized  that  these
R  receptor  types  act  in  concert,  allowing  the  formation
f  new  memories  relevant  to  the  stressful  situation.  In  this
ontext,  an  optimal  MR  functionality  may  be  pivotal  for  an
dequate  memory  formation  and  appraisal  during  stress.
herefore,  a  decreased  MR  functionality  could  have  detri-
ental  effects  on  stress-related  learning  and  impair  the
ppraisal  of  stressful  situations.  These  MR  effects  on  stress
ppraisal  are  plausible  in  light  of  the  selective  MR  expres-
ion  in  the  limbic  system  which  forms  the  interface  between
ncoming  sensory  information  and  the  selection  of  a learning
trategy.
. The MR and susceptibility for psychiatric
isorders
.1.  General
o  far,  we  have  summarized  the  evidence  for  a  role  of  the  MR
n  basal  and  stress-induced  HPA  axis  activity,  stress-related
ppraisal,  and  memory  formation.  This  begs  the  question
hat  the  implications  are  for  the  development  and  course
f  stress-related  psychiatric  disorders.  This  topic  is  also
elevant  in  light  of  the  overwhelming  number  of  studies
eporting  either  blunted  or  excessive  HPA-axis  activity  in
sychiatric  disorders  such  as  anxiety  disorders,  mood  disor-
ers,  and  schizophrenia  (Spijker  and  Van  Rossum,  2012).  We
herefore  expect  that  the  MR  plays  a  role  in  stress  resilience
nd  vulnerability.  Consequently,  variation  in  MR  expression
r  functionality  may,  at  least  partially,  determine  the  like-
ihood  that  an  individual  will  develop  a  psychiatric  disorder
fter  exposure  to  (traumatic)  stress.  Here,  we  will  discuss
he  evidence  linking  the  MR  to  susceptibility  for  psychiatric
isorders.
.2.  MR  expression  in  psychiatric  disorders
everal  postmortem  studies  have  investigated  MR  expression
n  psychiatric  disorders  which  have  yielded  quite  consistent
esults  (see  Table  2A).  Compared  to  non-depressed  subjects,
ostmortem  analysis  of  brains  of  MDD  patients  showed  a
ecrease  in  MR  mRNA  expression  in  the  hippocampus  (Klok
t  al.,  2011a;  Medina  et  al.,  2013),  inferior  frontal  gyrus,
nd  cingulate  gyrus  (Klok  et  al.,  2011a).  The  same  result
as  found  in  a  study  examining  hippocampal  MR  expression
f  suicide  victims  (Young  et  al.,  1998).  Similarly,  patients
ith  schizophrenia  and  bipolar  disorder  showed  a  decrease
n  expression  of  MR  mRNA  in  the  dorsolateral  prefrontal
ortex  (Qi  et  al.,  2013;  Xing  et  al.,  2004).  In  the  same
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tudy,  MR  mRNA  levels  were  negatively  correlated  with
he  duration  of  the  psychiatric  illness,  indicating  that  a
onger  duration  of  disease  was  associated  with  a  further
ecrease  of  MR  expression.  In  contrast,  one  study  found
n  increase  of  MR  expression  in  the  paraventricular  nucleus
PVN)  of  the  hypothalamus  in  MDD  which  may  compensatory
o  reduced  hippocampal  and  cortical  MR  expression  (Wang
t  al.,  2008).  Overall,  psychiatric  disorders  seem  to  be  con-
istently  accompanied  by  a  loss  of  MR  expression  in  limbic
reas  independent  of  psychiatric  diagnosis.  Such  a  decrease
n  MR  expression  would  result  in  a  reduced  MR-mediated
onic  inhibition  which  in  turn  could  chronically  elevate  cor-
isol  levels,  increasing  the  risk  for  MDD  after  stress  exposure.
his  may  also  be  related  to  secondary  changes  in  other
eurotransmitter  systems  such  as  the  5-HT  system  (Karten
t  al.,  1999).  In  support,  data  from  preclinical  studies  show
hat  various  classes  of  antidepressants  (among  which  MAO
nhibitors,  selective  serotonin  reuptake  inhibitors  (SSRIs),
nd  tricyclic  antidepressants  (TCAs))  consistently  increase
ippocampal  MR  expression  in  rodents  (Bjartmar  et  al.,
000;  Lopez  et  al.,  1998;  Reul  et  al.,  1994;  Seckl  and  Fink,
992;  Yau  et  al.,  1995)  (Table  2B).  This  effect  is,  in  part,
ependent  on  the  duration  of  antidepressant  treatment  as
t  has  been  shown  that,  in  contrast  to  long-term  treatment,
horter  treatment  (9  days)  with  either  ﬂuoxetine  or  ven-
afaxine  decreased  MR  mRNA  expression  in  all  hippocampal
ubregions  (Yau  et  al.,  2001).  In  the  context  of  the  rela-
ion  between  the  MR  and  antidepressants,  it  is  interesting
hat  the  effects  of  rs2070951  on  the  CAR  in  1026  individuals
rom  a  Dutch  longitudinal  cohort  occurred  only  in  individuals
aking  SSRIs  (Klok  et  al.,  2011c).  Moreover,  MR  expres-
ion  in  the  hippocampus  affects  5-HT1A receptor  expression
Rozeboom  et  al.,  2007).  Therefore,  clinically  used  antide-
ressants,  by  increasing  MR  expression,  could  restore
n  adequate  HPA-axis  functionality,  behavioral  response,
nd  enhance  recovery  from  depression  (Zobel  et  al.,
999).
.3.  MR-related  HPA-axis  functionality  in
sychiatric disorders
ood  disorder  patients  commonly  display  blunted  HPA-axis
uppression  after  administration  of  the  GR  agonist  dexa-
ethasone  (for  a  review  see  Spijker  and  Van  Rossum,  2012).
n  contrast,  prednisolone  —  which  has  comparable  GR  and
R  afﬁnity  —  appears  to  suppress  HPA-axis  activity  to  a
imilar  extent  in  both  MDD  patients  and  healthy  controls
Juruena  et  al.,  2010).  Moreover,  the  MR  antagonist  spirono-
actone  signiﬁcantly  enhanced  HPA-activity  in  MDD  patients
ompared  to  healthy  controls,  despite  the  chronically  ele-
ated  cortisol  levels  in  these  MDD  patients  (Young  et  al.,
003).  Conversely,  there  was  diminished  feedback  inhibition
f  the  HPA-axis  in  response  to  the  MR  agonist  ﬂudrocorti-
one  in  MDD  patients  compared  to  healthy  controls  (Lembke
t  al.,  2013).  Therefore,  the  current  evidence  suggest  that,
ven  though  MR  expression  may  be  decreased  in  MDD,
rain  MRs  can  still  alter  HPA-axis  activity  after  a  phar-
acological  challenge,  and  this  may  be  even  enhanced
n  MDD.  Nevertheless,  in  post-traumatic  stress  disorder
atients,  no  changes  in  MR  functionality  were  found  using  a
ombined  metyrapone-ﬂudrocortisone  test,  indicating  that
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Table  2  MR  expression  in  the  brain  of  individuals  with  a  psychiatric  disorder  (A)  and  effects  of  antidepressant  treatment  on
MR expression  in  the  rodent  brain  (B).
A:  Psychiatric  disorders  and  MR  expression  in  the  human  brain
Psychiatric  disorder  (N)  Brain  region  MR  expression  Reference
MDD  (12)  Hippocampus,  inferior
frontal  gyrus,  and
cingulate  gyrus
Decreased  (30%)  Klok  et  al.  (2011a)
MDD  (18)  Anterior  hippocampus  Decreased  (28%)  Medina  et  al.  (2013)
Suicide  victims  (12)  Hippocampus  Decreased  (37%)  Lopez  et  al.  (1998)
Schizophrenia,  bipolar  disorder  (49)  Dorsolateral  prefrontal
cortex
Decreased  (20%)  Xing  et  al.  (2004)
Bipolar  disorder  and  MDD  (14) Anterior  cingulate  cortex
and dorsolateral
prefrontal  cortex
Decreased  (38%) Qi  et  al.  (2013)
MDD  (14)  Hypothalamus  Increased  (54%)  Wang  et  al.  (2008)
B:  Antidepressant  use  and  MR  expression  in  the  rodent  brain
Antidepressant  Brain  region  MR  expression  Reference
Buspirone,  ﬂuoxetine,
and  moclobeminde
Hippocampus  Increased  for  all  3  antidepressants
(27—37%)
Bjartmar  et  al.  (2000)
Amitriptyline,
desipramine,  and
citalopram
Hippocampus  Increased  for  all  3  antidepressants  (23%)  Seckl  and  Fink  (1992)
Desipramine  Hippocampus  Reversal  of  stress-induced  decreases  in
MR
Lopez  et  al.  (1998)
Moclobemide  Hippocampus,
hypothalamus  and
neocortex
Increased  (hypothalamus  19—76%,
neocortex  24—44%),  unchanged
(hypothalamus)
Reul  et  al.  (1994)
Amitriptyline  Hippocampus  Increased  (17—28%) Yau  et  al.  (1995)
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rdifferences  and  variability  may  exist  across  psychiatric  dis-
orders  (Otte  et  al.,  2006).
5.4.  Genetic  MR  variation  and  susceptibility  for
psychiatric disorders
Surprisingly,  the  number  of  studies  linking  genetic  MR  vari-
ation  to  susceptibility  for  psychiatric  disorders  is  scarce.  A
recent  study  showed  that  the  CA  haplotype,  resulting  in  an
increased  MR  activity  (see  Table  1),  was  associated  with
enhanced  resilience  to  depression  in  females  from  a the
Dutch  NESDA  cohort  study  (N  =  3523)  (Klok  et  al.,  2011b).
In  two  other  independent  cohorts,  this  haplotype  was  asso-
ciated  with  a  higher  dispositional  optimism  (N  =  450)  and
fewer  thoughts  of  hopelessness  (N  =  150)  (Klok  et  al.,  2011b).
Consistently,  Val-allele  carriers  of  rs5522,  decreasing  MR
activity,  displayed  an  increased  vulnerability  for  depres-
sive  symptoms  in  elderly  individuals  (Kuningas  et  al.,  2007).
Therefore,  functional  MR  haplotypes  in  exon  2  of  NR3C2  not
only  affect  HPA-axis  functionality  but  also  have  behavioural
consequences  and  subsequently  inﬂuence  the  risk  for  psy-
chiatric  disorders.  In  these  studies,  the  effects  of  traumatic
stress  have  not  been  investigated  which  may  be  relevant
since  MR-related  depression  susceptibility  may  particularly
emerge  after  exposure  to  (traumatic)  stress.
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o.5.  The  MR  as  a drug  target  in  psychiatric
isorders
rom  the  previous  paragraphs,  it  is  apparent  that  sev-
ral  lines  of  evidence  generally  support  a  decreased  MR
xpression  or  functionality  in  mood  disorders.  Therefore,
ncreasing  MR  could  constitute  a  possible  treatment  for  MDD
s  well  as  other  psychiatric  disorders.  In  support,  ﬂudrocor-
isone  administration  in  both  healthy  woman  and  in  woman
uffering  from  borderline  personality  disorder  improved  the
motional  empathy  (Otte  et  al.,  2014).  This  suggests  that
he  MR  may  play  a  more  general  role  in  emotion  processing
nd  mood  across  psychiatric  disorders.
For  MDD,  there  is  convincing  evidence  that  the  MR  plays
n  important  role.  A  recent  double-blind  placebo-controlled
andomized  clinical  trial  indeed  showed  that  MR  activa-
ion  with  ﬂudrocortisone  as  an  add-on  treatment  in  64
DD  patients  receiving  treatment  with  the  SSRI  escitalo-
ram  showed  an  accelerated  antidepressant  response  of
pproximately  6  days  in  the  responder  group.  Escitalopram
esponders  receiving  ﬂudrocortisone  showed  decreasing  cor-
isol  levels  which  could  possibly  explain  the  accelerated
ntidepressant  effects  (Otte  et  al.,  2010).  This  corresponds
ith  ﬁndings  from  Holsboer  showing  that  the  MR  antag-
nist  spironolactone  decreased  the  antidepressant  effects
f  the  TCA  amitriptyline  (Holsboer,  1999).  Furthermore,
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dd-on  treatment  with  metyrapone,  a  cortisol  synthesis
nhibitor,  enhances  effectiveness  of  antidepressant  medica-
ion  which  was  hypothesized,  to  be  at  least  partially  due  to
etyrapone-induced  upregulation  of  hippocampal  MRs  (Jahn
t  al.,  2004).  In  summary,  there  are  indications  that  directly
r  indirectly  enhancing  MR  functionality  exerts  antidepres-
ant  effects.  Nevertheless,  this  effect  was  only  apparent  in
scitalopram  responders  but  not  in  escitalopram-resistant
atients  (Otte  et  al.,  2010).  As  a  result,  impaired  MR  func-
ion  may  predict  non-response  to  antidepressant  treatment.
n  support,  SSRI  responders  in  two  studies  showed  an  intact
R  functionality  in  response  to  the  prednisolone  suppres-
ion  test,  whereas  non-responders  displayed  impaired  MR
unctionality  (Juruena  et  al.,  2006,  2009).  Also,  the  absence
f  restoration  of  HPA-axis  response  to  the  MR  antagonist
pironolactone  in  treatment-resistant  MDD  patients  supports
he  notion  that  treatment  resistance  may  be  associated  with
mpaired  MR  functionality  (Juruena  et  al.,  2013).  In  this
ase,  further  stimulation  of  the  MR  may  not  be  possible  and
udrocortisone  may  not  be  effective  in  treatment-resistant
epression.  Interestingly,  MDD  patients  with  early  life  stress
howed  suppression  of  salivary  cortisol  levels  in  response  to
he  MR  agonist  ﬂudrocortisone  and  the  GR  agonist  dexameth-
sone,  indicating  comparable  MR  and  GR  sensitivity  (Baes
t  al.,  2014).  In  contrast,  MDD  patients  without  early  life
tress,  dexamethasone  but  no  ﬂudrocortisone  suppression
as  found.
Nevertheless,  chronic  aldosterone  treatment  in  rats
ncreased  anxiety  and  induced  depressive-like  phenotypes
Hlavacova  and  Jezova,  2008;  Hlavacova  et  al.,  2012).  This
ould  suggest  that  excessive  MR  stimulation  leads  to  an
ncreased  vulnerability  for  anxiety  and  depression  (Murck
t  al.,  2012),  even  though  chronic  aldosterone  treatment
id  not  induce  basal  or  stress-induced  HPA-axis  activity.  An
dditional  complicating  factor  is  the  fact  that  MR  activa-
ion  under  pro-inﬂammatory  conditions  in  cardiac  tissue
ncreases  cardiac  ﬁbrosis.  The  MR  antagonist  eplenorone
xerts  protective,  anti-inﬂammatory  effects  and  reduced
poptosis  in  myocytes  not  only  at  the  level  of  the  heart
ut  also  via  the  brain  MR  (Rafatian  et  al.,  2014).  This  indi-
ates  different  mechanisms  of  brain  MR  with  regard  to
sychopathology  as  opposed  to  pro-inﬂammatory  effects  of
R  stimulation.  Clearly,  these  seemingly  opposing  effects
hould  be  taken  into  account  during  clinical  application  of
R  agonists  or  antagonists.
.6.  Summary
n  summary,  evidence  for  a  role  of  the  MR  in  vulnerability
nd  resilience  for  psychiatric  disorders  stems  from  sev-
ral  lines  of  evidence:  postmortem  studies,  pharmacological
anipulations,  genetic  studies  and  treatment  studies.  These
onsistent  ﬁndings  are  not  surprising  as  a  maladaptive  stress
esponse  and  impaired  HPA-axis  functionality  commonly
ccur  in  psychiatric  disorders.  Therefore,  it  seems  plausible
hat,  in  addition  to  a  role  in  orchestrating  an  optimal  stress
esponse,  increased  MR  functionality  is  also  associated  with
esilience  to  MDD.  However,  studies  directly  investigating
he  moderating  role  of  the  MR  in  the  relation  between  trau-
atic  stress  and  the  development  of  psychiatric  disorders
re  lacking.
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. Sex-dependent effects of the MR:  an
verlooked but important topic
rom  the  previous  paragraphs,  it  may  have  appeared  that
he  role  of  the  brain  MR  is  rather  straightforward.  However,
ex  differences  in  MR  effects  are  frequently  reported  in  pre-
linical  and  clinical  studies.  These  sex-dependent  effects
re  plausible  from  a biological  perspective  in  light  of  the
fﬁnity  of  the  female  steroid  hormone  progesterone  for  the
R  (Carey  et  al.,  1995;  Quinkler  et  al.,  2002).  Furthermore,
estrogen  (Turner,  1990)  and  progesterone  (Castrén  et  al.,
995)  can  both  inﬂuence  MR  expression  levels.  Recently
he  oestrogen  receptor  was  found  to  inhibit  transactiva-
ional  effects  of  the  MR  in  several  cell  types  (Barrett  Mueller
t  al.,  2014).  This  could  account  for  the  decreased  occur-
ence  of  cardiovascular  diseases  in  premenopausal  woman.
ven  though  often  overlooked,  consistent  sex  differences
xist  in  the  cortisol  stress  response  which  is  dependent  on
emale  hormones  (Kudielka  and  Kirschbaum,  2005).  These
ex  differences  are  important  in  light  of  consistent  gender
ifferences  in  the  prevalence  of  stress-related  psychiatric
isorders  (Cyranowski  et  al.,  2000;  Piccinelli  and  Wilkinson,
000).  Here,  we  will  summarize  the  current  evidence  for
ex-dependent  MR  effects  in  preclinical  and  clinical  studies.
.1.  Preclinical  studies
reclinical  studies  support  a sex-dependent  regulation  of
R  expression  with  subsequent  behavioural  consequences.
irst,  basal  circular  hole  board  performance  was  inﬂuenced
y  the  estrous  cycle  in  female  mice  lacking  forebrain  MR
ompared  to  wildtype  mice  (Ter  Horst  et  al.,  2013).  More-
ver,  in  contrast  to  males,  female  mice  lacking  the  forebrain
R  were  unable  to  extinguish  fear  memory  (Ter  Horst  et  al.,
012a).  Furthermore,  hippocampal  MR  but  not  GR  expres-
ion  was  increased  in  female  mice  after  14  days  of  restraint
tress,  whereas  male  rats  showed  a  limited  MR  downreg-
lation  but  a strong  GR  downregulation  (Karandrea  et  al.,
000).  In  both  cases,  the  result  is  an  increased  MR:GR  ratio
n  both  sexes.  Comparably,  after  21  days  of  chronic  stress,
ale  rats  showed  decreased  GR  expression  but  no  changes
n  MR  expression  in  the  hippocampal  CA1  region  (Kitraki
t  al.,  2004).  In  contrast,  female  rats  showed  an  increased
R  expression  in  the  CA3  region  but  also  an  increase  in  GR
xpression  in  the  CA1  region.  The  increase  in  MR  expression
as  accompanied  by  an  improved  memory  performance.
n  another  study,  maternal  deprivation  and  chronic  unpre-
ictable  stress  resulted  in  distinct  sex-dependent  effects
n  MR  and  GR  hippocampal  expression  in  adulthood,  with
aternal  deprivation  inducing  long-term  GR  downregulation
n  males  (Llorente  et  al.,  2011).  In  adult  rats,  chronic  or
xcessive  stress  seems  to  increase  hippocampal  MR  expres-
ion  in  females  but  decrease  GR  expression  in  males.  In
ontrast,  chronic  unpredictable  stress  in  young  rats  sex-
ependently  affected  MR  expression  but  in  an  opposite
anner,  with  female  rats  showing  MR  downregulation  but  MR
pregulation  in  male  rats.  An  explanation  of  the  discrepancy
s  the  fact  that  rats  were  stressed  at  young  age  (4  weeks)  and
acriﬁced  47  days  later  at  reached  adulthood.  The  previous
tudies  used  adult  rats  which  were  sacriﬁced  directly  after
tress  exposure  (Karandrea  et  al.,  2000;  Kitraki  et  al.,  2004).
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This  delay  in  sacriﬁce  offers  a  time  frame  in  which  further
alteration  of  expression  is  possible.  In  summary,  even  though
not  completely  consistent,  these  studies  support  the  view
that  a  high  degree  of  sex-dependent  MR  (and  GR)  plasticity
exists  in  the  hippocampus  in  response  to  stress.
6.2.  Clinical  studies
In  addition  to  the  preclinical  evidence,  a number  of  clin-
ical  studies  have  pointed  to  sex-dependent  MR  effects  in
humans.  First,  as  previously  discussed,  resilience  to  depres-
sion  associated  with  the  MR  CA  haplotype  only  emerged  in
females  (Klok  et  al.,  2011b).  Moreover,  dexamethasone  sup-
pression  of  the  CAR  was  highest  in  female  carriers  of  the  GA
haplotype  whereas  male  GA  haplotype  carriers  showed  an
attenuated  suppression  (van  Leeuwen  et  al.,  2010b).  Also,
female  but  not  male  homozygotic  C-carriers  of  rs2070951
possessed  an  attenuated  CAR  increase  (Klok  et  al.,  2011c).
Sex  differences  also  exist  for  MR  mRNA  levels  in  the  human
hippocampus,  with  higher  concentrations  in  women  com-
pared  to  men  (Watzka  et  al.,  2000).  However,  not  all  studies
show  similar  sex-dependent  effects  (Kuningas  et  al.,  2007;
Muhtz  et  al.,  2011;  van  Leeuwen  et  al.,  2011).  Therefore,
sex  effects  relating  to  MR  functionality  and  expression  in
humans  appear  to  be  subtle,  diverse  and  are  not  yet  fully
understood.
6.3.  Summary
Based  on  preclinical  and  clinical  studies,  the  dynamics  of
MR  functionality  seems  to  be  of  particular  importance  in
females.  In  female  rats,  loss  of  MR  induces  memory  deﬁcien-
cies  whilst  an  increase  in  expression  of  the  MR  is  associated
with  resilience  to  depression  in  humans.  The  binding  of
female  sex  hormones  directly  to  the  MR,  a  direct  interaction
with  oestrogen  or  modulation  of  MR-expression  by  oestrogen
and  progesterone  could  explain  these  sex-dependent  effects
(Barrett  Mueller  et  al.,  2014).  Even  though  an  interaction
between  female  steroid  hormones  and  the  MR  is  evident,  it
is  currently  unknown  how  female  hormones  modulate  MR-
related  HPA-axis  activity  and  to  what  extent  these  effects
modulate  the  risk  for  stress-related  psychiatric  disorders
(for  a  review  see  Fernandez-Guasti  et  al.,  2012).
Nevertheless,  future  research  on  the  role  of  the  MR  in
stress  vulnerability  and  resilience  should  take  sex-speciﬁc
effects  into  account.  Considering  that  women  have  an
increased  risk  for  mood  disorders  compared  to  men,  sex-
dependent  MR  effects  could,  in  part,  play  a  role  in  these  sex
differences.
7. Discussion
An  adaptive  stress  response  is  essential  to  remain  healthy
and  overcome  the  detrimental  consequences  of  stress.  Both
the  MR  and  GR  are  important  in  determining  HPA-axis
activity,  stress  coping  and,  ultimately,  an  individual’s  vulner-
ability  for  psychiatric  disorders.  However,  whereas  GR  has
been  extensively  studied,  it  only  paints  half  of  the  picture.
Although  the  genomic  brain  MR  has  a  high  afﬁnity  for  cortisol
and  is  largely  occupied  under  basal  non-stress  conditions,
p
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t  is  clear  that  the  MR  also  plays  a  signiﬁcant  role  during
tressful  conditions  via  non-genomic  MRs  and  the  effects
f  genomic  MRs  in  setting  the  threshold  of  the  HPA  axis.
herefore,  even  though  the  MR  and  the  GR  work  in  a  com-
lementary  fashion  to  promote  an  adequate  coping  style,
he  MR  is  equally  important  as  the  GR.
In  summary,  there  is  convincing  evidence  that  the  MR
irectly  affects  basal  and  stress-induced  HPA-axis  activity
nd  stress-related  appraisal  and  learning  in  both  animals  and
umans.  From  the  literature,  an  increased  MR  expression  or
unctionality  seems  to  result  in  enhanced  stress  resilience
hich  reduces  the  risk  for  psychiatric  disorders.  In  accor-
ance,  patients  with  MDD  generally  show  a  reduced  MR
xpression.  Therefore,  it  may  be  argued  that  an  increase
n  MR  functionality  contributes  to  a  more  adaptive  stress
esponse  and  will  be  associated  with  an  increased  ability
o  cope  with  stressors.  In  contrast,  a  decrease  in  MR  func-
ionality  may  lead  to  a  maladaptive  stress  response  and
onsequently  increase  an  individual’s  vulnerability  for  the
ffects  of  chronic  stress.  The  discovery  of  a  membrane-
ound  MR  has  further  expanded  the  importance  of  the  MR
n  the  stress  response  as  this  receptor  type  has  a  distinct
unction  from  the  genomic  MR  (see  Box  1).  The  role  of
he  membrane-bound  MR  for  memory  retrieval  and  memory
ormation  during  stressful  situations  is  relevant  since  mal-
unctioning  of  memory  formation  alters  appraisal  of  stressful
ituations  and  can  increase  the  likelihood  of  developing  psy-
hiatric  disorders.
Moreover,  sex  differences  play  an  important  role  in  the
ndocrine  and  behavioural  effects  of  the  MR  and  are  of
irect  relevance  in  light  of  the  consistent  sex  differences  in
he  prevalence  of  stress-related  psychiatric  disorders.  Age
lso  affects  MR  expression,  and  this  is  directly  relevant  for
ex-dependent  MR  effects  considering  the  menopause.  Addi-
ionally,  the  ﬁnding  that  both  (traumatic)  stress  and  age
ffect  MR  functionality  is  of  interest  in  light  of  the  long-
asting  but  heterogeneous  MR  effects  of  traumatic  stress
cross  different  developmental  stages  of  life  (Pryce,  2008).
R  expression  is  not  constant  across  the  life  span,  and  stress
uring  certain  sensitive  periods  may  particularly  affect  MR
xpression  and  increase  the  risk  for  psychopathology.  To
ntegrate  the  different  aspects  of  the  MR  in  the  relation
etween  stress,  the  HPA-axis,  and  psychopathology,  Fig.  3
ummarizes  the  proposed  interactions  between  factors  in
haping  the  risk  for  psychiatric  disorders.
If  an  increase  in  brain  MR  expression  promotes  resilience
o  depression,  it  is  reasonable  to  assume  that  enhancing
R  functionality  may  be  used  as  a  potential  new  drug  tar-
et  in  the  treatment  of  psychiatric  disorders  (Kellner  and
iedemann,  2008).  Currently,  only  a  few  studies  have  been
ublished  in  which  an  MR  agonist  was  used  as  add-on  treat-
ent  for  depression  (see  Section  5.5),  but  no  large  RCTs  have
o  our  knowledge  been  carried  out.  Even  though  the  MR  may
onstitute  a  promising  drug  target,  the  applicability  of  MR
gonists  is  not  without  problems  in  light  of  the  effects  of
R  activation  in  the  kidney  and  its  role  in  inﬂammation.
his  effect  poses  a  challenge  for  the  direct  applicability
f  synthesized  (selective)  MR  agonists  in  the  treatment  of
sychiatric  disorders.
In  addition  to  the  MR  as  a  possible  drug  target,  genetic
ariation  in  the  MR  may  play  a  role  in  the  prediction
ho  are  at  risk  for  psychiatric  disorders  following  stress
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Figure  3  Overview  conceptualizing  how  the  MR  inﬂuences
resilience  or  vulnerability.  MR  activity  and/or  expression  appear
to be  at  least  dependent  on  sex  and  age,  (epi)genetic  varia-
tion and  exposure  to  (traumatic)  stress.  The  MR  is  an  important
stress  modulator  and  inﬂuences  stress  appraisal  and  fear-
related  memories.  Moreover,  the  MR  is  involved  basal  and
stress-induced  HPA-axis  activity,  determining  both  the  threshold
and the  magnitude  of  the  stress  response.  In  light  of  these  MR
effects,  MR  functionality  or  expression  can  inﬂuence  adaptive
behaviour  and  susceptibility  for  psychiatric  disorders.  Cortisol
is the  main  ligand  for  the  brain  MR  since  aldosterone  levels  in
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Bhe brain  are  very  low  (over  100-fold)  due  to  the  absence  of  the
ortisol  converting  enzyme  aldosterone  synthase.
xposure.  For  example,  common  and  functional  MR  haplo-
ypes  have  not  only  been  found  to  inﬂuence  HPA-axis  activity
nd  stress  appraisal,  but  also  the  risk  for  depression.  As
uch,  the  MR  genotype,  in  part,  could  determine  the  risk
or  stress-related  disorders.  However,  our  knowledge  on  the
nterplay  between  different  relevant  factors  is  currently
imited,  and  sex  and  age  probably  play  a  role  as  well.  There
s  also  some  preliminary  evidence  that  genetic  MR  varia-
ion  could  also  inﬂuence  treatment  efﬁcacy  for  MDD.  For
xample,  SSRI  use  affected  cortisol  levels  related  to  genetic
ariation  of  rs2070951,  suggesting  that  genetic  MR  variation
nd  SSRI  use  are  interrelated  (Klok  et  al.,  2011c).  On  the
ther  hand,  antidepressants  induce  MR  expression  (see  Sec-
ion  5.2)  which  may  be  one  of  the  mechanisms  underlying
he  effects  of  antidepressants.
In  conclusion,  there  is  increasing  and  convincing  evi-
ence  from  fundamental,  preclinical,  and  clinical  studies
hat  genomic  and  non-genomic  brain  MRs  are  important  in
ealth  and  disease.  These  results  have  put  the  MR  forward
s  a  principal  mediator  of  the  impact  of  stress  in  the  brain.
n  adequate  functionality  of  brain  MRs  allows  individuals
o  successfully  adapt  to  a  stressful  environment.  MR  func-
ionality  may  therefore,  in  turn,  determine  the  resilience
otential  of  an  individual.  In  contrast,  maladaptive  changes
BF.  ter  Heegde  et  al.
n  MR  expression  and  functionality  in  the  context  of  stress
an  increase  the  risk  for  psychiatric  disorders.  Even  though
here  is  some  evidence  that  targeting  the  MR  in  humans
ay  have  potential  beneﬁts,  either  as  a  genetic  risk  fac-
or  or  as  a  possible  pharmacological  treatment  target,  our
urrent  knowledge  is  still  limited.  Further  elucidation  of
eurobiological  pathways  underlying  MR-related  resilience
s  necessary  to  identify  who  is  at  risk  and  to  enhance  early
ntervention  strategies.
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